| Title | Author | Year | SCOPUS | PUBMED | ISI | TCI | |
|---|---|---|---|---|---|---|---|
| 1. | Management for improving patients' knowledge and understanding about drug allergy. | Jarernsiripornkul, N Chaipichit, N Chumworathayi, P Krska, J |
0 | ||||
| 2. | Patient reporting of potential adverse drug reactions: A methodological study | N Jarernsiripornkul J Krska PAG Capps RME Richards A Lee |
2002 | ||||
| 3. | Patient reporting of adverse drug reactions: useful information for pain management? | Jarernsiripornkul, N Krska, J Richards, RM Capps, PA |
2003 | ||||
| 4. | Prescription-Event Monitoring: New Systematic Approach of Adverse Drug Reaction Monitoring to New Drugs | Waraporn Kakaew Narumol Jarernsiripornkul |
2005 | ||||
| 5. | Randomized trial of atorvastatin in improving endothelial function in diabetics without prior coronary disease and having average cholesterol level | Tantikosoom, W Thinkhamrop, B Kiatchusakul, S Jarernsiripornkul, N Srinakarin, J Ojongpian, S |
2005 | ||||
| 6. | Adverse Drug Reaction Monitoring to Antiepileptic Drugs by Patient Self Reports | Piyanida Senacom Narumol Jarernsiripornkul Verawan Uchaipichat |
2008 | ||||
| 7. | Adverse drug reaction monitoring: Comparing doctor and patient reporting for new drugs | N. Jarernsiripornkul W. Kakaew W. Loalukkana J. Krska |
2009 | ||||
| 8. | Hospital pharmacists' activities and attitudes regarding the Thai safety monitoring program for new drugs | Jarernsiripornkul, N Krska, J Pongmanachai, M Nasritha, N |
2009 | ||||
| 9. | Knowledge, Understanding of Drug Allergy and Drug Allergy Card Carrying Behavior of Drug Allergic Patients in Srinagarind Hospital | Nataporn Chaipichit Narumol Jarernsiripornkul Pansu Chumworathayi |
2009 | ||||
| 10. | Patient self-reporting of potential adverse drug reactions to non-steroidal anti-inflammatory drugs in Thailand. | Jarernsiripornkul, N. Chaisrisawadsuk, S. Chaiyakum, A. Krska, J. |
2009 | ||||
| 11. | Patient reporting of suspected adverse drug reactions to antiepileptic drugs: factors affecting attribution accuracy. | Narumol Jarernsiripornkul Piyanida Senacom Verawan Uchaipichat Nataporn Chaipichit Janet Krska |
2012 | ||||
| 12. | Retrospective study of adverse drug reactions from warfarin: patient Self-reporting | N. Jarernsiripornkul C. Kantrong S. Lawong J. Krska |
2012 | ||||
| 13. | Adverse Drug Reactions Monitoring to Disease Modifying Antirheumatic Drugs (DMARDs) by Patient Self Reports | Pichayanin Ongtrakoolaree Narumol Jarernsiripornkul Ausanee Uajariyaku Ajanee Mahakkanukrauh |
2013 | ||||
| 14. | Survey of Nurses’ Roles and Attitudes towards Adverse Drug Reaction Monitoring and Reporting | Pannyada Horata Kanchanok Gniamsombat Siriluk Jaisue Narumol Jarernsiripornkul Khon Kaen 40002 Khon Kaen University |
2013 | ||||
| 15. | A qualitative study to explore how patients identify and assess symptoms as adverse drug reactions. | Nataporn Chaipichit Janet Krska Thongchai Pratipanawatr Verawan Uchaipichat Narumol Jarernsiripornkul |
2014 | ||||
| 16. | Hospital pharmacists’ roles and attitudes in providing information on the safety of non-steroidal anti-inflammatory drugs in Thailand | Phueanpinit, P Jarernsiripornkul, N Pongwecharak, J Krska, J |
2014 | ||||
| 17. | Patients' Attitude Towards Self-Reporting of Adverse Drug Reactions | Nataporn Chaipichit Narumol Jarernsiripornkul Verawan Uchaipichat Thongchai Pratipanawatr Janet Krska |
2014 | ||||
| 18. | การตระหนักถึงความปลอดภัยในการใช้ยาแก่ผู้ป่วยที่ได้รับยากลุ่ม NSAIDs ของเภสัชกรโรงพยาบาลในภาคตะวันออกเฉียงเหนือและทัศนคติต่อความจำเป็นในการให้ข้อมูลแก่ผู้ป่วย | พชรภรณ์ เผื่อนพินิจ จุราพร พงศ์เวชรักษ์ นฤมล เจริญศิริพรกุล |
2014 | ||||
| 19. | การสำรวจประสบการณ์การเกิดอาการไม่พึงประสงค์จากการใช้ยาของผู้ป่วยในโรงพยาบาล | อรุณโรจน์ ปัตสุรีย์ นฤมล เจริญศิริพรกุล |
2014 | ||||
| 20. | Experiences of adverse drug effects reported by patients in ambulatory clinic | Narumol Jarernsiripornkul Nataporn Chaipichit Janet Krska Verawan Uchaipichat Thongchai Pratipanawatr |
2015 | ||||
| 21. | Introducing self-reporting questionnaires about adverse drug reactions to patients: attitude towards their first experience | Nataporn Chaipichit Narumol Jarernsiripornkul Verawan Uchaipichat Thongchai Pratipanawatr Janet Krska |
2015 | ||||
| 22. | Management for improving patients’ knowledge and understanding about drug allergy | Jarernsiripornkul, N. Chaipichit, N. Chumworathayi, P. Krska, J. |
2015 | ||||
| 23. | Management for improving patients´ knowledge and understanding about drug allergy. Manejo para mejora del conocimiento y entendimiento de los pacientes sobre alergias a medicamentos | Narumol Jarernsiripornkul Nataporn Chaipichit Pansu Chumworathayi Janet Krska |
2015 | ||||
| 24. | Medicine information leaflets for non-steroidal anti-inflammatory drugs in Thailand | Pongwecharak, J. Krska, J. Jarernsiripornkul, N. |
2015 | ||||
| 25. | Statin adverse effects: patients' experiences and laboratory monitoring of muscle and liver injuries. | Nataporn Chaipichit Janet Krska Thongchai Pratipanawatr Narumol Jarernsiripornkul |
2015 | ||||
| 26. | SURVEY OF INFORMATION SOURCES ON DRUG SAFETY IN PATIENTS TAKING NON-STEROIDAL ANTI-INFLAMMATORY DRUGS | N. Jarernsiripornkul P. Phueanpinit J. Pongwecharak J. Krska |
2015 | ||||
| 27. | Survey of patients' experiences and their certainty of suspected adverse drug reactions | Narumol, J Arunrot, P Krska, J |
2015 | ||||
| 28. | Experiences of and attitudes towards receiving information about non-steroidal anti-inflammatory drugs: a cross-sectional survey of patients in Thailand | Jarernsiripornkul, N Phueanpinit, P Pongwecharak, J Krska, J |
2016 | ||||
| 29. | Experiences relating to adverse drug reactions in the community: A cross-sectional survey among patients and the general public in Thailand | Patsuree, A Krska, J Jarernsiripornkul, N |
2016 | ||||
| 30. | Initial development and testing of an instrument for patient self-assessment of adverse drug reactions | Narumol Jarernsiripornkul Nataporn Chaipichit Thongchai Pratipanawatr Verawan Uchaipichat Janet Krska |
2016 | ||||
| 31. | Knowledge and perceptions of the risks of non-steroidal anti-inflammatory drugs among orthopaedic patients in Thailand | Pacharaporn Phueanpinit Juraporn Pongwecharak Janet Krska Narumol Jarernsiripornkul |
2016 | ||||
| 32. | Medicine information leaflets for non-steroidal anti-inflammatory drugs in Thailand. | Pongwecharak, J. Krska, J. Jarernsiripornkul, N. |
2016 | ||||
| 33. | Physicians' communication of risks from non-steroidal anti-inflammatory drugs and attitude towards providing adverse drug reaction information to patients | Pacharaporn Phueanpinit Juraporn Pongwecharak Sermsak Sumanont Janet Krska Narumol Jarernsiripornkul |
2017 | ||||
| 34. | Public confidence in ADR identification and their views on ADRreporting: mixed methods study. | Jarernsiripornkul, N. Krska, J. |
2017 | ||||
| 35. | Attitude towards usefulness of patient information leaflets among ambulatory patients | Supawinee Pongpunna Thongchai Pratipanawatr Narumol Jarernsiripornkul |
2018 | ||||
| 36. | Confidence and accuracy in identification of adverse drug reactions reported by outpatients | Kampichit, S Pratipanawatr, T Jarernsiripornkul, N |
2018 | ||||
| 37. | Evaluation of community pharmacists' roles in screening and communication of risks about non-steroidal anti-inflammatory drugs in Thailand | Pongwecharak, J. Krska, J. Jarernsiripornkul, N. |
2018 | ||||
| 38. | Screening and prevention of non-steroidal anti-inflammatory drug risk: Doctors and hospital pharmacists' roles | Narumol Jarernsiripornkul Pacharaporn Phueanpinit Juraporn Pongwecharak Janet Krska |
2018 | ||||
| 39. | Development and evaluation of user-tested Thai patient information leaflets for nonsteroidal anti-inflammatory drugs: Effect on patients' knowledge | Jarernsiripornkul, N Phueanpinit, P Pongwecharak, J Krska, J |
2019 | ||||
| 40. | Practices of healthcare professionals in communicating with nonsteroidal anti-inflammatory drug users in Thailand: a qualitative study | Jarernsiripornkul, N Phueanpinit, P Pongwecharak, J Krska, J |
2019 | ||||
| 41. | Survey of outpatients' use and needs of patient medicine information leaflets in Thailand. | Pratipanawatr, T. Jarernsiripornkul, N. |
2019 | ||||
| 42. | Experiences and Views of Medicine Information Among the General Public in Thailand. | Krska, J. Pongwecharak, J. Jarernsiripornkul, N. |
2020 | ||||
| 43. | Survey of healthcare professionals' practices, expectations, and attitudes towards provision of patient information leaflets in Thailand | Jarernsiripornkul, N Nakboon, S Anarj, K Wongtaweepkij, K |
2020 | ||||
| 44. | Development and psychometric validation for evaluating written medicine information in Thailand: The Consumer Information Rating Form | Kamonphat Wongtaweepkij Janet Krska Juraporn Pongwecharak Supawinee Pongpunna Narumol Jarernsiripornkul |
2021 | ||||
| 45. | Evaluation of Patient's Knowledge of Atorvastatin Information in Patient Information Leaflets: A Pre-Post Intervention Study in Thailand. | Supawinee Pongpunna Thongchai Pratipanawatr Kamonphat Wongtaweepkij Narumol Jarernsiripornkul |
2021 | ||||
| 46. | Patients' Experiences and Perspectives of Receiving Written Medicine Information About Medicines: A Qualitative Study. | Krska, J. Pongwecharak, J. Jarernsiripornkul, N. |
2021 | ||||
| 47. | Evaluation of patient comprehension and quality of consumer medicine information | Pongpunna, S. Wongtaweepkij, K. Pratipanawatr, T. Jarernsiripornkul, N. |
2022 | ||||
| 48. | Exploring Healthcare Professionals’ Practices and Attitudes towards Monitoring and Reporting of Severe Adverse Drug Reactions | Srisuriyachanchai, W. Cox, A.R. Jarernsiripornkul, N. |
2022 | ||||
| 49. | Thai Patients' Drug Safety Knowledge and Perceptions Relating to Different Forms of Written Medicine Information: A Comparative Study. | Krska, J. Pongpunna, S. Pongwecharak, J. Jarernsiripornkul, N. |
2022 | ||||
| 50. | A nationwide survey of methods and barriers to adverse drug reaction monitoring and reporting among hospital pharmacists in Thailand. | Jarernsiripornkul, N Kayrash, S Homket, P Srisuriyachanchai, W |
2023 | ||||
| 51. | Evaluation of Medicine Information Leaflets for Omeprazole, Safety Knowledge, and Perceptions of Taking the Medication in Thailand. | Wongtaweepkij, K. Sup-Adulchai, N. Chanachoat, J. Krska, J. Jarernsiripornkul, N. |
2023 | ||||
| 52. | Severity and Management of Adverse Drug Reactions Reported by Patients and Healthcare Professionals: A Cross-Sectional Survey | Srisuriyachanchai, W. Cox, A.R. Kampichit, S. Jarernsiripornkul, N. |
2023 | ||||
| 53. | Accuracy in patient-reported adverse drug reactions and their recognition: a mixed-methods study. | Kampichit, S. Srisuriyachanchai, W. Pratipanawatr, T. Jarernsiripornkul, N. |
2024 | ||||
| 54. | Comparing patient reported and medical record data of adverse drug reactions to anti-seizure drugs. | Jarernsiripornkul, N. Tiamkao, S. Wongtaweepkij, K. Jorns, T.P. Junsuaydee, K. Nontasen, N. Gayrash, S. Kampichit, S. |
2024 | ||||
| 55. | Patients’ Identification, Management and Prevention of Adverse Drug Reactions: A Cross-Sectional Survey of Patients with Severe Adverse Drug Reactions | Srisuriyachanchai, W. Cox, A.R. Jarernsiripornkul, N. |
2024 | ||||
| 56. | Practices of community pharmacists during the COVID-19 pandemic: potential barriers and views on providing pharmacy services in Thailand | Jarernsiripornkul, N. Wongtaweepkij, K. Pason, D. Namwan, T. |
2024 | ||||
| 57. | Drug-Induced Serious Cutaneous Reactions in Hospitalized Patients: A Cross-Sectional Study | Jiamsathit, W. Bunarong, K. Papenkort, S. Cox, A.R. Jarernsiripornkul, N. |
2025 | ||||
| 58. | Evaluation of a self-screening tool and patient alert cards to help patients identify and manage severe adverse drug reactions | Srisuriyachanchai, W Foocharoen, C Mahakkanukrauh, A Cox, AR Jarernsiripornkul, N |
2025 | ||||
| 59. | Public self-reported adverse experience and knowledge about use of herbal and dietary supplements | Wongtaweepkij, K Srinonghang, S Youngpattana, W Summa, K Papenkort, S Cox, AR Jarernsiripornkul, N |
2025 | ||||
| 60. | Self-reporting of adverse drug reactions of nonsteroidal anti-inflammatory drugs in community pharmacies. | Olson, PS Krska, J Taengthonglang, C Tansin, P Siangtrong, W Pongrueangdilok, P Jarernsiripornkul, N Potisarach, P |
2025 | Count | 41 | 37 | 34 | 8 |
| Title | Authors | Year | Publication name | Cited count | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| < 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Total | ||||||
| 1. | Patient reporting of potential adverse drug reactions: A methodological study | Jarernsiripornkul, N. Krska, J. Capps, P.A.G. Lee, A. |
2002 |
British Journal of Clinical Pharmacology 3 (53), pp. 318-325 |
||||||||
| 2. | Patient reporting of adverse drug reactions: Useful information for pain management? | Jarernsiripornkul, N. Krska, J. Capps, P.A.G. |
2003 |
European Journal of Pain 3 (7), pp. 219-224 |
||||||||
| 3. | Randomized trial of atorvastatin in improving endothelial function in diabetics without prior coronary disease and having average cholesterol level | Thinkhamrop, B. Kiatchusakul, S. Jarernsiripornkul, N. Srinakarin, J. Ojongpian, S. |
2005 |
Journal of the Medical Association of Thailand 3 (88), pp. 399-406 |
||||||||
| 4. | Adverse drug reaction monitoring: Comparing doctor and patient reporting for new drugs | Jarernsiripornkul, N. Kakaew, W. Loalukkana, W. Krska, J. |
2009 |
Pharmacoepidemiology and Drug Safety 3 (18), pp. 240-245 |
||||||||
| 5. | Hospital pharmacists' activities and attitudes regarding the Thai safety monitoring program for new drugs | Jarernsiripornkul, N. Krska, J. Pongmanachai, M. Nasritha, N. |
2009 |
Pharmacoepidemiology and Drug Safety 9 (18), pp. 837-841 |
||||||||
| 6. | Patient self-reporting of potential adverse drug reactions to non-steroidal anti-inflammatory drugs in Thailand | Jarernsiripornkul, N. Chaisrisawadsuk, S. Chaiyakum, A. Krska, J. |
2009 |
Pharmacy World and Science 5 (31), pp. 559-564 |
||||||||
| 7. | Patient reporting of suspected adverse drug reactions to antiepileptic drugs: Factors affecting attribution accuracy | Jarernsiripornkul, N. Senacom, P. Uchaipichat, V. Chaipichit, N. Krska, J. |
2012 |
Epilepsy and Behavior 1 (24), pp. 102-106 |
||||||||
| 8. | A qualitative study to explore how patients identify and assess symptoms as adverse drug reactions | Chaipichit, N. Krska, J. Pratipanawatr, T. Uchaipichat, V. Jarernsiripornkul, N. |
2014 |
European Journal of Clinical Pharmacology 5 (70), pp. 607-615 |
||||||||
| 9. | Hospital pharmacists’ roles and attitudes in providing information on the safety of non-steroidal anti-inflammatory drugs in Thailand | Jarernsiripornkul, N. Pongwecharak, J. Krska, J. |
2014 |
International Journal of Clinical Pharmacy 6 (36), pp. 1205-1212 |
||||||||
| 10. | Management for improving patients’ knowledge and understanding about drug allergy | Jarernsiripornkul, N. Chaipichit, N. Chumworathayi, P. Krska, J. |
2015 |
Pharmacy Practice 1 (13), pp. |
||||||||
| 11. | Medicine information leaflets for non-steroidal anti-inflammatory drugs in Thailand | Pongwecharak, J. Krska, J. Jarernsiripornkul, N. |
2015 |
International Journal of Clinical Pharmacy (), pp. 1-5 |
||||||||
| 12. | Statin adverse effects: patients’ experiences and laboratory monitoring of muscle and liver injuries | Chaipichit, N. Krska, J. Pratipanawatr, T. Jarernsiripornkul, N. |
2015 |
International Journal of Clinical Pharmacy (), pp. |
||||||||
| 13. | Statin adverse effects: patients’ experiences and laboratory monitoring of muscle and liver injuries | Chaipichit, N. Krska, J. Pratipanawatr, T. Jarernsiripornkul, N. |
2015 |
International Journal of Clinical Pharmacy 2 (37), pp. 355-364 |
||||||||
| 14. | Experiences of and attitudes towards receiving information about non-steroidal anti-inflammatory drugs: A cross-sectional survey of patients in Thailand | Jarernsiripornkul, N. Pongwecharak, J. Krska, J. |
2016 |
Expert Opinion on Drug Safety 4 (15), pp. 417-426 |
||||||||
| 15. | Experiences relating to adverse drug reactions in the community: A cross-sectional survey among patients and the general public in Thailand | Krska, J. Jarernsiripornkul, N. |
2016 |
Expert Opinion on Drug Safety 3 (15), pp. 287-295 |
||||||||
| 16. | Initial development and testing of an instrument for patient self-assessment of adverse drug reactions | Jarernsiripornkul, N. Chaipichit, N. Pratipanawatr, T. Uchaipichat, V. Krska, J. |
2016 |
Pharmacoepidemiology and Drug Safety 1 (25), pp. 54-63 |
||||||||
| 17. | Knowledge and perceptions of the risks of non-steroidal anti-inflammatory drugs among orthopaedic patients in Thailand | Pongwecharak, J. Krska, J. Jarernsiripornkul, N. |
2016 |
International Journal of Clinical Pharmacy 5 (38), pp. 1269-1276 |
||||||||
| 18. | Medicine information leaflets for non-steroidal anti-inflammatory drugs in Thailand | Pongwecharak, J. Krska, J. Jarernsiripornkul, N. |
2016 |
International Journal of Clinical Pharmacy 1 (38), pp. 25-29 |
||||||||
| 19. | Physicians' communication of risks from non-steroidal anti-inflammatory drugs and attitude towards providing adverse drug reaction information to patients | Pongwecharak, J. Sumanont, S. Krska, J. Jarernsiripornkul, N. |
2017 |
Journal of Evaluation in Clinical Practice 6 (23), pp. 1387-1394 |
||||||||
| 20. | Public confidence in ADR identification and their views on ADRreporting: mixed methods study | Jarernsiripornkul, N. Krska, J. |
2017 |
European Journal of Clinical Pharmacology 2 (73), pp. 223-231 |
||||||||
| 21. | Confidence and accuracy in identification of adverse drug reactions reported by outpatients | Pratipanawatr, T. Jarernsiripornkul, N. |
2018 |
International Journal of Clinical Pharmacy 6 (40), pp. 1559-1567 |
||||||||
| 22. | Evaluation of community pharmacists' roles in screening and communication of risks about non-steroidal anti-inflammatory drugs in Thailand | Pongwecharak, J. Krska, J. Jarernsiripornkul, N. |
2018 |
Primary Health Care Research and Development 6 (19), pp. 598-604 |
||||||||
| 23. | Development and evaluation of user-tested Thai patient information leaflets for non-steroidal anti-inflammatory drugs: Effect on patients' knowledge | Jarernsiripornkul, N. Pongwecharak, J. Krska, J. |
2019 |
PLoS ONE 1 (14), pp. |
||||||||
| 24. | Practices of healthcare professionals in communicating with nonsteroidal anti-inflammatory drug users in Thailand: a qualitative study | Jarernsiripornkul, N. Pongwecharak, J. Krska, J. |
2019 |
International Journal of Pharmacy Practice 4 (27), pp. 362-369 |
||||||||
| 25. | Survey of outpatients’ use and needs of patient medicine information leaflets in Thailand | Pratipanawatr, T. Jarernsiripornkul, N. |
2019 |
International Journal of Clinical Pharmacy 1 (41), pp. 141-150 |
||||||||
| 26. | Experiences and views of medicine information among the general public in Thailand | Krska, J. Pongwecharak, J. Jarernsiripornkul, N. |
2020 |
Patient Preference and Adherence (14), pp. 1073-1082 |
||||||||
| 27. | Survey of healthcare professionals’ practices, expectations, and attitudes towards provision of patient information leaflets in Thailand | Jarernsiripornkul, N. | 2020 |
International Journal of Clinical Pharmacy 2 (42), pp. 539-548 |
||||||||
| 28. | Development and psychometric validation for evaluating written medicine information in Thailand: The Consumer Information Rating Form | Krska, J. Pongwecharak, J. Pongpunna, S. Jarernsiripornkul, N. |
2021 |
BMJ Open 10 (11), pp. |
||||||||
| 29. | Evaluation of patient’s knowledge of atorvastatin information in patient information leaflets: A pre-post intervention study in thailand | Pongpunna, S. Pratipanawatr, T. Jarernsiripornkul, N. |
2021 |
Patient Preference and Adherence (15), pp. 2377-2387 |
||||||||
| 30. | Patients’ experiences and perspectives of receiving written medicine information about medicines: A qualitative study | Krska, J. Pongwecharak, J. Jarernsiripornkul, N. |
2021 |
Patient Preference and Adherence (15), pp. 569-580 |
||||||||
| 31. | Evaluation of patient comprehension and quality of consumer medicine information | Pongpunna, S. Wongtaweepkij, K. Pratipanawatr, T. Jarernsiripornkul, N. |
2022 |
Pharmacy Practice 4 (20), pp. |
||||||||
| 32. | Exploring Healthcare Professionals’ Practices and Attitudes towards Monitoring and Reporting of Severe Adverse Drug Reactions | Srisuriyachanchai, W. Cox, A.R. Jarernsiripornkul, N. |
2022 |
Healthcare (Switzerland) 6 (10), pp. |
||||||||
| 33. | Thai Patients’ Drug Safety Knowledge and Perceptions Relating to Different Forms of Written Medicine Information: A Comparative Study | Krska, J. Pongpunna, S. Pongwecharak, J. Jarernsiripornkul, N. |
2022 |
Patient Preference and Adherence (16), pp. 1141-1152 |
||||||||
| 34. | Evaluation of Medicine Information Leaflets for Omeprazole, Safety Knowledge, and Perceptions of Taking the Medication in Thailand | Wongtaweepkij, K. Sup-Adulchai, N. Chanachoat, J. Krska, J. Jarernsiripornkul, N. |
2023 |
Patient Preference and Adherence (17), pp. 883-893 |
||||||||
| 35. | Severity and Management of Adverse Drug Reactions Reported by Patients and Healthcare Professionals: A Cross-Sectional Survey | Srisuriyachanchai, W. Cox, A.R. Kampichit, S. Jarernsiripornkul, N. |
2023 |
International Journal of Environmental Research and Public Health 4 (20), pp. |
||||||||
| 36. | Accuracy in patient-reported adverse drug reactions and their recognition: a mixed-methods study | Kampichit, S. Srisuriyachanchai, W. Pratipanawatr, T. Jarernsiripornkul, N. |
2024 |
International Journal of Clinical Pharmacy 2 (46), pp. 401-410 |
||||||||
| 37. | Comparing patient reported and medical record data of adverse drug reactions to anti-seizure drugs | Jarernsiripornkul, N. Tiamkao, S. Wongtaweepkij, K. Jorns, T.P. Junsuaydee, K. Nontasen, N. Gayrash, S. Kampichit, S. |
2024 |
International Journal of Clinical Pharmacy 1 (46), pp. 101-110 |
||||||||
| 38. | Patients’ Identification, Management and Prevention of Adverse Drug Reactions: A Cross-Sectional Survey of Patients with Severe Adverse Drug Reactions | Srisuriyachanchai, W. Cox, A.R. Jarernsiripornkul, N. |
2024 |
Journal of Clinical Medicine 14 (13), pp. |
||||||||
| 39. | Practices of community pharmacists during the COVID-19 pandemic: potential barriers and views on providing pharmacy services in Thailand | Jarernsiripornkul, N. Wongtaweepkij, K. Pason, D. Namwan, T. |
2024 |
Pharmacy Practice 2 (22), pp. |
||||||||
| 40. | Drug-Induced Serious Cutaneous Reactions in Hospitalized Patients: A Cross-Sectional Study | Jiamsathit, W. Bunarong, K. Papenkort, S. Cox, A.R. Jarernsiripornkul, N. |
2025 |
Journal of Clinical Medicine 3 (14), pp. |
||||||||
| 41. | Evaluation of a self-screening tool and patient alert cards to help patients identify and manage severe adverse drug reactions | Srisuriyachanchai, W. Foocharoen, C. Mahakkanukrauh, A. Cox, A.R. Jarernsiripornkul, N. |
2025 |
International Journal of Clinical Pharmacy 3 (47), pp. 726-736 |
||||||||
| 42. | Public self-reported adverse experience and knowledge about use of herbal and dietary supplements | Wongtaweepkij, K. Srinonghang, S. Youngpattana, W. Summa, K. Papenkort, S. Cox, A.R. Jarernsiripornkul, N. |
2025 |
BMC Complementary Medicine and Therapies 1 (25), pp. |
||||||||
| Title | Authors | Year | Journal title | ||
|---|---|---|---|---|---|
| 1. | Patient reporting of potential adverse drug reactions: a methodological study. | Jarernsiripornkul, N Krska, J Capps, PA Richards, RM Lee, A |
2002 |
British journal of clinical pharmacology 3 (53), pp. 318-25 |
|
| 2. | Patient reporting of adverse drug reactions: useful information for pain management? | Jarernsiripornkul, N Krska, J Richards, RM Capps, PA |
2003 |
European journal of pain (London, England) 3 (7), pp. 219-24 |
|
| 3. | Randomized trial of atorvastatin in improving endothelial function in diabetics without prior coronary disease and having average cholesterol level. | Tantikosoom, W Thinkhamrop, B Kiatchusakul, S Jarernsiripornkul, N Srinakarin, J Ojongpian, S |
2005 |
Journal of the Medical Association of Thailand = Chotmaihet thangphaet 3 (88), pp. 399-406 |
|
| 4. | Hospital pharmacists' activities and attitudes regarding the Thai safety monitoring program for new drugs. | Jarernsiripornkul, N Krska, J Pongmanachai, M Nasritha, N |
2009 |
Pharmacoepidemiology and drug safety 9 (18), pp. 837-41 |
|
| 5. | Patient self-reporting of potential adverse drug reactions to non-steroidal anti-inflammatory drugs in Thailand. | Jarernsiripornkul, N Chaisrisawadsuk, S Chaiyakum, A Krska, J |
2009 |
Pharmacy world & science : PWS 5 (31), pp. 559-64 |
|
| 6. | Adverse drug reaction monitoring: comparing doctor and patient reporting for new drugs. | Jarernsiripornkul, N Kakaew, W Loalukkana, W Krska, J |
2009 |
Pharmacoepidemiology and drug safety 3 (18), pp. 240-5 |
|
| 7. | Patient reporting of suspected adverse drug reactions to antiepileptic drugs: factors affecting attribution accuracy. | Jarernsiripornkul, N Senacom, P Uchaipichat, V Chaipichit, N Krska, J |
2012 |
Epilepsy & behavior : E&B 1 (24), pp. 102-6 |
|
| 8. | A qualitative study to explore how patients identify and assess symptoms as adverse drug reactions. | Chaipichit, N Krska, J Pratipanawatr, T Uchaipichat, V Jarernsiripornkul, N |
2014 |
European journal of clinical pharmacology 5 (70), pp. 607-15 |
|
| 9. | Hospital pharmacists' roles and attitudes in providing information on the safety of non-steroidal anti-inflammatory drugs in Thailand. | Phueanpinit, P Jarernsiripornkul, N Pongwecharak, J Krska, J |
2014 |
International journal of clinical pharmacy 6 (36), pp. 1205-12 |
|
| 10. | Statin adverse effects: patients' experiences and laboratory monitoring of muscle and liver injuries. | Chaipichit, N Krska, J Pratipanawatr, T Jarernsiripornkul, N |
2015 |
International journal of clinical pharmacy 2 (37), pp. 355-64 |
|
| 11. | Survey of patients' experiences and their certainty of suspected adverse drug reactions. | Narumol, J Arunrot, P Krska, J |
2015 |
International journal of clinical pharmacy 1 (37), pp. 168-74 |
|
| 12. | Knowledge and perceptions of the risks of non-steroidal anti-inflammatory drugs among orthopaedic patients in Thailand. | Phueanpinit, P Pongwecharak, J Krska, J Jarernsiripornkul, N |
2016 |
International journal of clinical pharmacy 5 (38), pp. 1269-76 |
|
| 13. | Initial development and testing of an instrument for patient self-assessment of adverse drug reactions. | Jarernsiripornkul, N Chaipichit, N Pratipanawatr, T Uchaipichat, V Krska, J |
2016 |
Pharmacoepidemiology and drug safety 1 (25), pp. 54-63 |
|
| 14. | Experiences of and attitudes towards receiving information about non-steroidal anti-inflammatory drugs: a cross-sectional survey of patients in Thailand. | Jarernsiripornkul, N Phueanpinit, P Pongwecharak, J Krska, J |
2016 |
Expert opinion on drug safety 4 (15), pp. 417-26 |
|
| 15. | Medicine information leaflets for non-steroidal anti-inflammatory drugs in Thailand. | Phueanpinit, P Pongwecharak, J Krska, J Jarernsiripornkul, N |
2016 |
International journal of clinical pharmacy 1 (38), pp. 25-9 |
|
| 16. | Experiences relating to adverse drug reactions in the community: a cross-sectional survey among patients and the general public in Thailand. | Patsuree, A Krska, J Jarernsiripornkul, N |
2016 |
Expert opinion on drug safety (), pp. 1-9 |
|
| 17. | Public confidence in ADR identification and their views on ADRreporting: mixed methods study. | Jarernsiripornkul, N Patsuree, A Krska, J |
2017 |
European journal of clinical pharmacology 2 (73), pp. 223-231 |
|
| 18. | Physicians' communication of risks from non-steroidal anti-inflammatory drugs and attitude towards providing adverse drug reaction information to patients. | Phueanpinit, P Pongwecharak, J Sumanont, S Krska, J Jarernsiripornkul, N |
2017 |
Journal of evaluation in clinical practice 6 (23), pp. 1387-1394 |
|
| 19. | Confidence and accuracy in identification of adverse drug reactions reported by outpatients. | Kampichit, S Pratipanawatr, T Jarernsiripornkul, N |
2018 |
International journal of clinical pharmacy 6 (40), pp. 1559-1567 |
|
| 20. | Evaluation of community pharmacists' roles in screening and communication of risks about non-steroidal anti-inflammatory drugs in Thailand. | Phueanpinit, P Pongwecharak, J Krska, J Jarernsiripornkul, N |
2018 |
Primary health care research & development (), pp. 1-7 |
|
| 21. | Development and evaluation of user-tested Thai patient information leaflets for non-steroidal anti-inflammatory drugs: Effect on patients' knowledge. | Jarernsiripornkul, N Phueanpinit, P Pongwecharak, J Krska, J |
2019 |
PloS one 1 (14), pp. e0210395 |
|
| 22. | Practices of healthcare professionals in communicating with nonsteroidal anti-inflammatory drug users in Thailand: a qualitative study. | Jarernsiripornkul, N Phueanpinit, P Pongwecharak, J Krska, J |
2019 |
The International journal of pharmacy practice 4 (27), pp. 362-369 |
|
| 23. | Survey of outpatients' use and needs of patient medicine information leaflets in Thailand. | Pongpunna, S Pratipanawatr, T Jarernsiripornkul, N |
2019 |
International journal of clinical pharmacy 1 (41), pp. 141-150 |
|
| 24. | Experiences and Views of Medicine Information Among the General Public in Thailand. | Wongtaweepkij, K Krska, J Pongwecharak, J Jarernsiripornkul, N |
2020 |
Patient preference and adherence (14), pp. 1073-1082 |
|
| 25. | Survey of healthcare professionals' practices, expectations, and attitudes towards provision of patient information leaflets in Thailand. | Jarernsiripornkul, N Nakboon, S Anarj, K Wongtaweepkij, K |
2020 |
International journal of clinical pharmacy 2 (42), pp. 539-548 |
|
| 26. | Development and psychometric validation for evaluating written medicine information in Thailand: The Consumer Information Rating Form. | Wongtaweepkij, K Krska, J Pongwecharak, J Pongpunna, S Jarernsiripornkul, N |
2021 |
BMJ open 10 (11), pp. e053740 |
|
| 27. | Patients' Experiences and Perspectives of Receiving Written Medicine Information About Medicines: A Qualitative Study. | Wongtaweepkij, K Corlett, S Krska, J Pongwecharak, J Jarernsiripornkul, N |
2021 |
Patient preference and adherence (15), pp. 569-580 |
|
| 28. | Evaluation of Patient's Knowledge of Atorvastatin Information in Patient Information Leaflets: A Pre-Post Intervention Study in Thailand. | Pongpunna, S Pratipanawatr, T Wongtaweepkij, K Jarernsiripornkul, N |
2021 |
Patient preference and adherence (15), pp. 2377-2387 |
|
| 29. | Thai Patients' Drug Safety Knowledge and Perceptions Relating to Different Forms of Written Medicine Information: A Comparative Study. | Wongtaweepkij, K Krska, J Pongpunna, S Pongwecharak, J Jarernsiripornkul, N |
2022 |
Patient preference and adherence (16), pp. 1141-1152 |
|
| 30. | A nationwide survey of methods and barriers to adverse drug reaction monitoring and reporting among hospital pharmacists in Thailand. | Jarernsiripornkul, N Kayrash, S Homket, P Srisuriyachanchai, W |
2023 |
The International journal of pharmacy practice 6 (31), pp. 625-632 |
|
| 31. | Evaluation of Medicine Information Leaflets for Omeprazole, Safety Knowledge, and Perceptions of Taking the Medication in Thailand. | Wongtaweepkij, K Sup-Adulchai, N Chanachoat, J Krska, J Jarernsiripornkul, N |
2023 |
Patient preference and adherence (17), pp. 883-893 |
|
| 32. | Accuracy in patient-reported adverse drug reactions and their recognition: a mixed-methods study. | Kampichit, S Srisuriyachanchai, W Pratipanawatr, T Jarernsiripornkul, N |
2024 |
International journal of clinical pharmacy 2 (46), pp. 401-410 |
|
| 33. | Comparing patient reported and medical record data of adverse drug reactions to anti-seizure drugs. | Jarernsiripornkul, N Tiamkao, S Wongtaweepkij, K Jorns, TP Junsuaydee, K Nontasen, N Gayrash, S Kampichit, S |
2024 |
International journal of clinical pharmacy 1 (46), pp. 101-110 |
|
| 34. | Public self-reported adverse experience and knowledge about use of herbal and dietary supplements. | Wongtaweepkij, K Srinonghang, S Youngpattana, W Summa, K Papenkort, S Cox, AR Jarernsiripornkul, N |
2025 |
BMC complementary medicine and therapies 1 (25), pp. 226 |
|
| 35. | Evaluation of a self-screening tool and patient alert cards to help patients identify and manage severe adverse drug reactions. | Srisuriyachanchai, W Foocharoen, C Mahakkanukrauh, A Cox, AR Jarernsiripornkul, N |
2025 |
International journal of clinical pharmacy 3 (47), pp. 726-736 |
|
| 36. | Self-reporting of adverse drug reactions of nonsteroidal anti-inflammatory drugs in community pharmacies. | Olson, PS Krska, J Taengthonglang, C Tansin, P Siangtrong, W Pongrueangdilok, P Jarernsiripornkul, N Potisarach, P |
2025 |
Journal of pharmaceutical policy and practice 1 (18), pp. 2483419 |
|
| 37. | Management for improving patients' knowledge and understanding about drug allergy. | Jarernsiripornkul, N Chaipichit, N Chumworathayi, P Krska, J |
Pharmacy practice 1 (13), pp. 513 |
| Title | Authors | Year | Journal title | Cited count | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| < 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Total | ||||||
| 1. | Patient reporting of potential adverse drug reactions: a methodological study | N Jarernsiripornkul J Krska PAG Capps RME Richards A Lee |
2002 |
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY 3.0 (53.0), pp. 318.0-325.0 |
59 | 0 | 0 | 0 | 0 | 0 | 59 | |
| 2. | Patient reporting of adverse drug reactions: useful information for pain management? | N Jarernsiripornkul J Krska RME Richards PAG Capps |
2003 |
EUROPEAN JOURNAL OF PAIN 3.0 (7.0), pp. 219.0-224.0 |
45 | 0 | 0 | 0 | 0 | 0 | 45 | |
| 3. | Adverse drug reaction monitoring: comparing doctor and patient reporting for new drugs | N. Jarernsiripornkul W. Kakaew W. Loalukkana J. Krska |
2009 |
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 3.0 (18.0), pp. 240.0-245.0 |
40 | 0 | 0 | 0 | 0 | 0 | 40 | |
| 4. | Hospital pharmacists' activities and attitudes regarding the Thai safety monitoring program for new drugs | N. Jarernsiripornkul J. Krska M. Pongmanachai N. Nasritha |
2009 |
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 9.0 (18.0), pp. 837.0-841.0 |
4 | 0 | 0 | 0 | 0 | 0 | 4 | |
| 5. | Patient self-reporting of potential adverse drug reactions to non-steroidal anti-inflammatory drugs in Thailand | Narumol Jarernsiripornkul Sudarat Chaisrisawadsuk Aporanee Chaiyakum Janet Krska |
2009 |
PHARMACY WORLD & SCIENCE 5.0 (31.0), pp. 559.0-564.0 |
18 | 0 | 0 | 0 | 0 | 0 | 18 | |
| 6. | Patient reporting of suspected adverse drug reactions to antiepileptic drugs: Factors affecting attribution accuracy | Narumol Jarernsiripornkul Piyanida Senacom Verawan Uchaipichat Nataporn Chaipichit Janet Krska |
2012 |
EPILEPSY & BEHAVIOR 1.0 (24.0), pp. 102.0-106.0 |
13 | 0 | 0 | 0 | 0 | 0 | 13 | |
| 7. | Retrospective study of adverse drug reactions from warfarin: patient Self-reporting | N. Jarernsiripornkul C. Kantrong S. Lawong J. Krska |
2012 |
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 1.0 (21.0), pp. 114.0-114.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 8. | A qualitative study to explore how patients identify and assess symptoms as adverse drug reactions | Nataporn Chaipichit Janet Krska Thongchai Pratipanawatr Verawan Uchaipichat Narumol Jarernsiripornkul |
2014 |
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY 5.0 (70.0), pp. 607.0-615.0 |
34 | 0 | 0 | 0 | 0 | 0 | 34 | |
| 9. | Hospital pharmacists' roles and attitudes in providing information on the safety of non-steroidal anti-inflammatory drugs in Thailand | Pacharaporn Phueanpinit Narumol Jarernsiripornkul Juraporn Pongwecharak Janet Krska |
2014 |
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY 6.0 (36.0), pp. 1205.0-1212.0 |
14 | 0 | 0 | 0 | 0 | 0 | 14 | |
| 10. | Experiences of adverse drug effects reported by patients in ambulatory clinic | Narumol Jarernsiripornkul Nataporn Chaipichit Janet Krska Verawan Uchaipichat Thongchai Pratipanawatr |
2015 |
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY 1.0 (37.0), pp. 213.0-213.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 11. | Introducing self-reporting questionnaires about adverse drug reactions to patients: attitude towards their first experience | Nataporn Chaipichit Narumol Jarernsiripornkul Verawan Uchaipichat Thongchai Pratipanawatr Janet Krska |
2015 |
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY 1.0 (37.0), pp. 224.0-225.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 12. | Management for improving patients´ knowledge and understanding about drug allergy. Manejo para mejora del conocimiento y entendimiento de los pacientes sobre alergias a medicamentos | Narumol Jarernsiripornkul Nataporn Chaipichit Pansu Chumworathayi Janet Krska |
2015 |
Pharmacy Practice (Internet) 1.0 (13.0), pp. 0.0-0.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 13. | Statin adverse effects: patients' experiences and laboratory monitoring of muscle and liver injuries | Nataporn Chaipichit Janet Krska Thongchai Pratipanawatr Narumol Jarernsiripornkul |
2015 |
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY 2.0 (37.0), pp. 355.0-364.0 |
22 | 0 | 0 | 0 | 0 | 0 | 22 | |
| 14. | SURVEY OF INFORMATION SOURCES ON DRUG SAFETY IN PATIENTS TAKING NON-STEROIDAL ANTI-INFLAMMATORY DRUGS | N. Jarernsiripornkul P. Phueanpinit J. Pongwecharak J. Krska |
2015 |
CLINICAL THERAPEUTICS 8.0 (37.0), pp. E36-E36 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 15. | Survey of patients' experiences and their certainty of suspected adverse drug reactions | Jarernsiripornkul Narumol Patsuree Arunrot Janet Krska |
2015 |
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY 1.0 (37.0), pp. 168.0-174.0 |
12 | 0 | 0 | 0 | 0 | 0 | 12 | |
| 16. | Experiences of and attitudes towards receiving information about non-steroidal anti-inflammatory drugs: a cross-sectional survey of patients in Thailand | Narumol Jarernsiripornkul Pacharaporn Phueanpinit Juraporn Pongwecharak Janet Krska |
2016 |
EXPERT OPINION ON DRUG SAFETY 4.0 (15.0), pp. 417.0-426.0 |
15 | 0 | 0 | 0 | 0 | 0 | 15 | |
| 17. | Experiences relating to adverse drug reactions in the community: a cross-sectional survey among patients and the general public in Thailand | Arunrot Patsuree Janet Krska Narumol Jarernsiripornkul |
2016 |
EXPERT OPINION ON DRUG SAFETY 3.0 (15.0), pp. 287.0-295.0 |
18 | 0 | 0 | 0 | 0 | 0 | 18 | |
| 18. | Initial development and testing of an instrument for patient self-assessment of adverse drug reactions | Narumol Jarernsiripornkul Nataporn Chaipichit Thongchai Pratipanawatr Verawan Uchaipichat Janet Krska |
2016 |
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 1.0 (25.0), pp. 54.0-63.0 |
6 | 0 | 0 | 0 | 0 | 0 | 6 | |
| 19. | Knowledge and perceptions of the risks of non-steroidal anti-inflammatory drugs among orthopaedic patients in Thailand | Pacharaporn Phueanpinit Juraporn Pongwecharak Janet Krska Narumol Jarernsiripornkul |
2016 |
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY 5.0 (38.0), pp. 1269.0-1276.0 |
16 | 0 | 0 | 0 | 0 | 0 | 16 | |
| 20. | Medicine information leaflets for non-steroidal anti-inflammatory drugs in Thailand | Pacharaporn Phueanpinit Juraporn Pongwecharak Janet Krska Narumol Jarernsiripornkul |
2016 |
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY 1.0 (38.0), pp. 25.0-29.0 |
17 | 0 | 0 | 0 | 0 | 0 | 17 | |
| 21. | Physicians' communication of risks from non-steroidal anti-inflammatory drugs and attitude towards providing adverse drug reaction information to patients | Pacharaporn Phueanpinit Juraporn Pongwecharak Sermsak Sumanont Janet Krska Narumol Jarernsiripornkul |
2017 |
JOURNAL OF EVALUATION IN CLINICAL PRACTICE 6.0 (23.0), pp. 1387.0-1394.0 |
23 | 0 | 0 | 0 | 0 | 0 | 23 | |
| 22. | Public confidence in ADR identification and their views on ADRreporting: mixed methods study | Narumol Jarernsiripornkul Arunrot Patsuree Janet Krska |
2017 |
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY 2.0 (73.0), pp. 223.0-231.0 |
14 | 0 | 0 | 0 | 0 | 0 | 14 | |
| 23. | Attitude towards usefulness of patient information leaflets among ambulatory patients | Supawinee Pongpunna Thongchai Pratipanawatr Narumol Jarernsiripornkul |
2018 |
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY 1.0 (40.0), pp. 276.0-277.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 24. | Confidence and accuracy in identification of adverse drug reactions reported by outpatients | Sirinya Kampichit Thongchai Pratipanawatr Narumol Jarernsiripornkul |
2018 |
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY 6.0 (40.0), pp. 1559.0-1567.0 |
8 | 0 | 0 | 0 | 0 | 0 | 8 | |
| 25. | Evaluation of community pharmacists' roles in screening and communication of risks about non-steroidal anti-inflammatory drugs in Thailand | Pacharaporn Phueanpinit Juraporn Pongwecharak Janet Krska Narumol Jarernsiripornkul |
2018 |
PRIMARY HEALTH CARE RESEARCH AND DEVELOPMENT 6.0 (19.0), pp. 598.0-604.0 |
9 | 0 | 0 | 0 | 0 | 0 | 9 | |
| 26. | Screening and prevention of non-steroidal anti-inflammatory drug risk: Doctors and hospital pharmacists' roles | Narumol Jarernsiripornkul Pacharaporn Phueanpinit Juraporn Pongwecharak Janet Krska |
2018 |
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY 1.0 (40.0), pp. 268.0-268.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 27. | Development and evaluation of user-tested Thai patient information leaflets for nonsteroidal anti-inflammatory drugs: Effect on patients' knowledge | Narumol Jarernsiripornkul Pacharaporn Phueanpinit Juraporn Pongwecharak Janet Krska |
2019 |
PLOS ONE 1.0 (14.0), pp. |
10 | 0 | 0 | 0 | 0 | 0 | 10 | |
| 28. | Practices of healthcare professionals in communicating with nonsteroidal anti-inflammatory drug users in Thailand: a qualitative study | Narumol Jarernsiripornkul Pacharaporn Phueanpinit Juraporn Pongwecharak Janet Krska |
2019 |
INTERNATIONAL JOURNAL OF PHARMACY PRACTICE 4.0 (27.0), pp. 362.0-369.0 |
6 | 0 | 0 | 0 | 0 | 0 | 6 | |
| 29. | Survey of outpatients' use and needs of patient medicine information leaflets in Thailand | Supawinee Pongpunna Thongchai Pratipanawatr Narumol Jarernsiripornkul |
2019 |
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY 1.0 (41.0), pp. 141.0-150.0 |
8 | 0 | 0 | 0 | 0 | 0 | 8 | |
| 30. | Experiences and Views of Medicine Information Among the General Public in Thailand | Kamonphat Wongtaweepkij Janet Krska Juraporn Pongwecharak Narumol Jarernsiripornkul |
2020 |
PATIENT PREFERENCE AND ADHERENCE (14.0), pp. 1073.0-1082.0 |
1 | 0 | 0 | 0 | 0 | 0 | 1 | |
| 31. | Survey of healthcare professionals' practices, expectations, and attitudes towards provision of patient information leaflets in Thailand | Narumol Jarernsiripornkul Sireerat Nakboon Kobkaew Anarj Kamonphat Wongtaweepkij |
2020 |
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY 2.0 (42.0), pp. 539.0-548.0 |
3 | 0 | 0 | 0 | 0 | 0 | 3 | |
| 32. | Development and psychometric validation for evaluating written medicine information in Thailand: The Consumer Information Rating Form | Kamonphat Wongtaweepkij Janet Krska Juraporn Pongwecharak Supawinee Pongpunna Narumol Jarernsiripornkul |
2021 |
BMJ OPEN 10.0 (11.0), pp. |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 33. | Evaluation of Patient's Knowledge of Atorvastatin Information in Patient Information Leaflets: A Pre- Post Intervention Study in Thailand | Supawinee Pongpunna Thongchai Pratipanawatr Kamonphat Wongtaweepkij Narumol Jarernsiripornkul |
2021 |
PATIENT PREFERENCE AND ADHERENCE (15.0), pp. 2377.0-2387.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 34. | Patients' Experiences and Perspectives of Receiving Written Medicine Information About Medicines: A Qualitative Study | Kamonphat Wongtaweepkij Sarah Corlett Janet Krska Juraporn Pongwecharak Narumol Jarernsiripornkul |
2021 |
PATIENT PREFERENCE AND ADHERENCE (15.0), pp. 569.0-580.0 |
1 | 0 | 0 | 0 | 0 | 0 | 1 | |
| Title | Authors | Year | Journal title | ||
|---|---|---|---|---|---|
| 1. | Prescription-Event Monitoring: New Systematic Approach of Adverse Drug Reaction Monitoring to New Drugs | Waraporn Kakaew Narumol Jarernsiripornkul |
2005 |
Srinagarind Medical Journal (20 No 4), pp. 270-275 |
|
| 2. | Adverse Drug Reaction Monitoring to Antiepileptic Drugs by Patient Self Reports | Piyanida Senacom Narumol Jarernsiripornkul Verawan Uchaipichat |
2008 |
Srinagarind Medical Journal (23 No 4), pp. 373-382 |
|
| 3. | Knowledge, Understanding of Drug Allergy and Drug Allergy Card Carrying Behavior of Drug Allergic Patients in Srinagarind Hospital | Nataporn Chaipichit Narumol Jarernsiripornkul Pansu Chumworathayi |
2009 |
Srinagarind Medical Journal (24 No 3), pp. 224-230 |
|
| 4. | Survey of Nurses’ Roles and Attitudes towards Adverse Drug Reaction Monitoring and Reporting | Pannyada Horata Kanchanok Gniamsombat Siriluk Jaisue Narumol Jarernsiripornkul Khon Kaen 40002 Khon Kaen University |
2013 |
Isan Journal of Pharmaceutical Sciences (9 No 1), pp. 29 |
|
| 5. | Adverse Drug Reactions Monitoring to Disease Modifying Antirheumatic Drugs (DMARDs) by Patient Self Reports | Pichayanin Ongtrakoolaree Narumol Jarernsiripornkul Ausanee Uajariyaku Ajanee Mahakkanukrauh |
2013 |
Srinagarind Medical Journal (28 No 3), pp. 302-310 |
|
| 6. | Patients' Attitude Towards Self-Reporting of Adverse Drug Reactions | Nataporn Chaipichit Narumol Jarernsiripornkul Verawan Uchaipichat Thongchai Pratipanawatr Janet Krska |
2014 |
Srinagarind Medical Journal (29 No 5), pp. 461-468 |
|
| 7. | การตระหนักถึงความปลอดภัยในการใช้ยาแก่ผู้ป่วยที่ได้รับยากลุ่ม NSAIDs ของเภสัชกรโรงพยาบาลในภาคตะวันออกเฉียงเหนือและทัศนคติต่อความจำเป็นในการให้ข้อมูลแก่ผู้ป่วย | พชรภรณ์ เผื่อนพินิจ จุราพร พงศ์เวชรักษ์ นฤมล เจริญศิริพรกุล |
2014 |
Isan Journal of Pharmaceutical Sciences (9 No 3), pp. 179 |
|
| 8. | การสำรวจประสบการณ์การเกิดอาการไม่พึงประสงค์จากการใช้ยาของผู้ป่วยในโรงพยาบาล | อรุณโรจน์ ปัตสุรีย์ นฤมล เจริญศิริพรกุล |
2014 |
Isan Journal of Pharmaceutical Sciences (9 No 3), pp. 183 |
| Title | Authors | NRIIS type | Year | NRIIS Scholarship | ||
|---|---|---|---|---|---|---|
| 1. | การประเมินและประยุกต์ใช้เอกสารกำกับยาสำหรับผู้ป่วยภาษาไทยในผู้ป่วยนอกและประชากรทั่วไป |
รศ.ดร. นฤมล เจริญศิริพรกุล นางสาวสุภาวิณี พงษ์พันนา นายธงชัย ประฏิภาณวัตร |
โครงการ | 2561 | ทุนงบประมาณแผ่นดินประจำปี 2561 (งบบูรณาการวิจัยและนวัตกรรม) |